FGFR1 and cancer: PD173074 is a potent inhibitor of FGFR1 and VEGFR, and it was also shown to effectively resensitize chemoresistant cancer cells overexpressing ABCB1 and ABCC10 to some chemotherapeutic agents, including paclitaxel.